78246-81-8

Basic information

• Product Name: benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside
• Synonyms: benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside
• CAS NO: 78246-81-8
• Molecular Weight: 399.444
• Mol File: 78246-81-8.mol
• Article Data: 28

Chemical Properties

• CAS DataBase Reference: benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside(78246-81-8)
• EPA Substance Registry System: benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside(78246-81-8)

Safety Data

• Hazardous Substances Data: 78246-81-8(Hazardous Substances Data)

Upstream product

• 7512-17-6 N-Acetyl-D-glucosamine 
• 10036-64-3 N-acetyl-D-glucosamine 
• 100-51-6 benzyl alcohol 
• 1078691-95-8 (+)-D-glucosamine hydrochloride 
• 1125-88-8 benzaldehyde dimethyl acetal 
• 25320-99-4 benzyl α-D-glucopyranoside 
• 2873-29-2 D-glucal triacetate 
• 95451-80-2 Benzyl-3,4,6-tri-O-acetyl-2-azido-2-desoxy-α-D-mannopyranosid 
• 68733-20-0 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-α-D-mannopyranoside 
• 95451-81-3 Benzyl-2-azido-2-desoxy-α-D-mannoopyranosid 
• 95451-93-7 3,4,6-Tri-O-acetyl-2-azido-2-deoxy-α-D-mannopyranosyl bromide 
• 35812-81-8 Benzyl-2-amino-2-desoxy-α-D-mannopyranosid 
• 79549-73-8 benzyl 4,6-O-(phenylmethylene)-α-D-glucopyranoside 
• 492-62-6 alpha-D-glucopyranose 

Downstream Products

• 144741-50-4 3-acetyl-2-carboxy-(benzyl-4,6-O-benzylidene-2,3-dideoxy-α-D-glucopyranosido)<2,3-d>oxazolidine 
• 136982-79-1 benzyl 2-acetamido-3-O-acetyl-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside 
• 152696-82-7 3-acetyl-(benzyl 4,6-O-benzylidene-2,3-dideoxy-α-D-glucopyranosido)<2,3-d>oxazolidine 
• 73089-68-6 benzyl 2-acetamido-4,6-O-benzylidene-3-O-[(R)-1-carboxyethyl]-2-deoxy-α-D-glucopyranoside 
• 356785-89-2 ((2R,4aR,6S,7R,8R,8aS)-7-Acetylamino-6-benzyloxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-8-yloxymethyl)-(1,1-diethoxy-ethyl)-phosphinic acid ethyl ester 
• 917029-91-5 benzyl 2-acetamido-6-O-acetyl-2-deoxy-3-O-(D-1-{[2-(phenylsulfonyl)ethoxy]carbonyl}ethyl)-α-D-glucopyranoside 
• 914642-50-5 benzyl 2-acetamido-6-O-benzyl-2-deoxy-3-O-(D-1-{[2-(phenylsulfonyl)ethoxy]carbonyl}ethyl)-α-D-glucopyranoside 
• 917030-07-0 (R)-2-[(2R,3S,4R,5R,6S)-2-Acetoxymethyl-5-acetylamino-3-((2S,3R,4R,5S,6R)-4,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-2-yloxy)-6-hydroxy-tetrahydro-pyran-4-yloxy]-propionic acid 2-benzenesulfonyl-ethyl ester 
• 917029-93-7 benzyl 3,4,6-tri-O-acethyl-2-deoxy-2-acetamido-β-D-glucopyranosyl-(1->4)-2-acetamido-6-O-acetyl-2-deoxy-3-O-(D-1-{[2-(phenylsulfonyl)ethoxy]carbonyl}ethyl)-α-D-glucopyranoside 
• 917030-10-5 (R)-2-[(2R,3S,4R,5R,6R)-2-Acetoxymethyl-5-acetylamino-3-((2S,3R,4R,5S,6R)-4,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-2-yloxy)-6-phosphonooxy-tetrahydro-pyran-4-yloxy]-propionic acid 2-benzenesulfonyl-ethyl ester 
• 917029-92-6 benzyl 3,4,6-tri-O-acetyl-2-deoxy-2-[(2,2,2-trichloroethoxy)carbonylamino]-β-D-glucopyranosyl-(1->4)-2-acetamido-6-O-benzyl-2-deoxy-3-O-(D-1-{[2-(phenylsulfonyl)ethoxy]carbonyl}ethyl)-α-D-glucopyranoside 
• 917029-99-3 dibenzyl 3,4,6-tri-O-acetyl-2-deoxy-2-acetamido-β-D-glucopyranosyl-(1->4)-2-acetamido-6-O-acetyl-2-deoxy-3-O-(D-1-{[N-hydroxysuccinimidyloxy)carbonyl]ethyl}-α-D-glucopyranosyl phosphate 
• 917029-94-8 dibenzyl 3,4,6-tri-O-acethyl-2-deoxy-2-acetamido-β-D-glucopyranosyl-(1->4)-2-acetamido-6-O-acetyl-2-deoxy-3-O-(D-1-{[2-(phenylsulfonyl)ethoxy]carbonyl}ethyl)-α-D-glucopyranosyl phosphate 
• 917030-02-5 dibenzyl 3,4,6-tri-O-acetyl-2-deoxy-2-acetamido-β-D-glucopyranosyl-(1->4)-2-acetamido-6-O-acetyl-2-deoxy-3-O-(D-2-propionyl-L-alanyl-D-glutamic diamide)-α-D-glucopyranosyl phosphate 

Relevant articles and documents

Solid phase synthesis of muramyl dipeptides on isomeric trialkoxybenzylamine resins

New isomeric trialkoxybenzylamine resins are developed coupling phthalimidomethyl-3,5-dimethoxyphenols to the Merrifield resin, followed by subsequent treatment with hydrazine. The generated benzylamine function allows DCC coupling with the carboxyl funct

SYNTHETIC INNATE IMMUNE RECEPTOR LIGANDS AND USES THEREOF

An adjuvant formulation includes a monophosphoryl Lipid A (MPLA) analogue, a Pam3CSK4 analogue, or a muramyldipeptide (MDP) analogue, or combinations thereof. The adjuvant may be formulated in soluble form or in a nanoparticle, such as polylactic glycolic acid nanoparticles. A vaccine formulation comprises the adjuvant formulation and an immunogen. Methods of vaccinating an animal include delivering the vaccine formulation to the animal.

NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF

The invention relates to novel Muramyl Dipeptide (MDP) derivative compound of structural Formula-VIII, a process for synthesis, intermediates used in the synthesis and use thereof. R = alkyl (both linear and branched), aryl, substituted aryl, alkoxy alkyl Wherein, R can be both linear and branched alkyl, aryl, substituted aryl and alkoxy alkyl. These compounds possess excellent pharmacological properties, in particular immunomodulating properties for use as adjuvant in vaccine formulations. These compounds are, particularly useful as adjuvants in vaccines.